Incidence and burden of long COVID in Africa: a systematic review and meta-analysis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 Dec 2023
06 Dec 2023
Historique:
received:
31
07
2023
accepted:
24
11
2023
medline:
11
12
2023
pubmed:
7
12
2023
entrez:
6
12
2023
Statut:
epublish
Résumé
Long COVID, also known as "post-acute sequelae of COVID-19," affects at least 65 million individuals worldwide with a wide spectrum of symptoms that may last weeks, months, or permanently. Its epidemiology and burden in Africa are unclear. This meta-analysis examines long-term COVID-19 effects in the WHO African Region. A systematic search in several databases was carried out up to 12 February 2023 including observational studies from African countries reporting the cumulative incidence of long COVID signs and symptoms. Only studies conducted in African countries were included. Several sensitivity and meta-regression analyses were performed. Among 1547 papers initially screened, 25 were included, consisting of 29,213 participants. The incidence of any long COVID symptomatology was 48.6% (95% CI 37.4-59.8) as psychiatric conditions were the most frequent, particularly post-traumatic stress disorder reaching a cumulative incidence of 25% (95% CI 21.1-30.4). Higher age (p = 0.027) and hospitalization (p = 0.05) were associated with a higher frequency of long COVID. Long COVID poses a significant burden in Africa, particularly concerning psychiatric conditions. The study recommends identifying at-risk people and defining treatment strategies and recommendations for African long-COVID patients. High-quality studies addressing this condition in African setting are urgently needed.
Identifiants
pubmed: 38057338
doi: 10.1038/s41598-023-48258-3
pii: 10.1038/s41598-023-48258-3
pmc: PMC10700349
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21482Informations de copyright
© 2023. The Author(s).
Références
J Clin Med. 2022 Jan 14;11(2):
pubmed: 35054108
Eur Arch Psychiatry Clin Neurosci. 2023 Sep;273(6):1349-1358
pubmed: 36707454
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Lancet Infect Dis. 2022 Jan;22(1):43-55
pubmed: 34480857
Lancet Glob Health. 2022 Sep;10(9):e1247-e1256
pubmed: 35961348
Brain Behav Immun. 2022 Mar;101:93-135
pubmed: 34973396
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
EClinicalMedicine. 2021 May 24;36:100899
pubmed: 34036253
Lancet Reg Health Eur. 2021 Dec;11:100242
pubmed: 34746909
Int J Infect Dis. 2023 Mar;128:102-111
pubmed: 36587841
PLoS One. 2015 Jan 24;10(1):e0116949
pubmed: 25617837
J Clin Med. 2022 Mar 11;11(6):
pubmed: 35329867
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Pharm Stat. 2021 Jan;20(1):185-195
pubmed: 32935459
Viruses. 2022 Aug 24;14(9):
pubmed: 36146672
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16
pubmed: 34763058
Intern Emerg Med. 2023 Aug;18(5):1573-1581
pubmed: 36449260
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Int J Environ Res Public Health. 2022 Jun 03;19(11):
pubmed: 35682448
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901
J Med Virol. 2021 Apr;93(4):2307-2320
pubmed: 33247599
Syst Rev. 2021 Apr 19;10(1):117
pubmed: 33875004
Lancet Glob Health. 2018 Sep;6(9):e954-e955
pubmed: 30103990
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608